New study aims to unlock the Mind-Body connection in women with chronic pain and PTSD
NCT ID NCT07313280
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at women who have both chronic pain conditions (central sensitization syndromes) and post-traumatic stress disorder (PTSD). First, researchers will identify different psychological patterns in these women. Then, they will test a personalized talk therapy approach to see if it helps reduce symptoms like anxiety and emotional distress. The goal is to better understand and treat this complex combination of conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 12 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2025
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. being a biological woman. 2. having a medical diagnosis of CSS. 3. scoring \>36 on the Posttraumatic Stress Disorder Checklist for DSM-5, which indicates PTSD in people with chronic pain. 4. having the ability to understand and sign the informed consent form. Exclusion Criteria: 1. having a diagnosis of serious mental illness or neurodegenerative disease. 2. not being fluent in spoken and written Spanish. 3. undergoing treatment for an oncological, degenerative, or terminal disease.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Central sensitization are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
3 sites. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Hospital Universitario Regional de Málaga_Hospital Civil
Málaga, Málaga, 29009, Spain
-
Hospital Universitario Virgen de la Victoria
Málaga, Málaga, 29010, Spain
-
Área de Gestión Sanitaria Este de Málaga-Axarquía
Málaga, Torre Del Mar, 29740, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Is chronic elbow pain really a Whole-Body nerve problem?
- Can a short CBT session curb Post-Surgery opioid dependence?
- Could a new pill quiet chronic pain? early trial puts it to the test
- Can a coordinated care team ease the aftermath of intensive care?
- Can a smartphone app curb PTSD and drinking after sexual assault?
- Retraining the brain to turn down neck pain — a new approach put to the test